Benzodiazepines: Harmful Effects, Help, Healing and Support: 3 Modules

References

• Agarwal, S. D., & Landon, B. E. (2019). Patterns in Outpatient Benzodiazepine Prescribing in the United States. JAMA network open, 2(1), e187399. https://doi.org/10.1001/jamanetworkopen.2018.7399
• Ashton H. (2005). The diagnosis and management of benzodiazepine dependence. Current opinion in psychiatry, 18(3), 249–255. https://doi.org/10.1097/01.yco.0000165594.60434.84
• Barros, V. V., Opaleye, E. S., & Noto, A. R. (2018). Is the regulation of Z-drugs in Brazil in line with scientific research and international standards?. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 40(1), 112. https://doi.org/10.1590/1516-4446-2017-2372
• Cocker, F., & Joss, N. (2016). Compassion Fatigue among Healthcare, Emergency and Community Service Workers: A Systematic Review. International journal of environmental research and public health, 13(6), 618. https://doi.org/10.3390/ijerph13060618
• Colorado Consortium for Prescription Drug Abuse Prevention. (2022). Benzodiazepine Deprescribing Guidance. https://corxconsortium.org/wp-content/uploads/Benzo-Deprescribing.pdf.
• Dodds T. J. (2017). Prescribed Benzodiazepines and Suicide Risk: A Review of the Literature. The primary care companion for CNS disorders, 19(2), 10.4088/PCC.16r02037. https://doi.org/10.4088/PCC.16r02037
• Fixsen, A. M., & Ridge, D. (2017). Stories of Hell and Healing: Internet Users' Construction of Benzodiazepine Distress and Withdrawal. Qualitative health research, 27(13), 2030–2041. https://doi.org/10.1177/1049732317728053
• Foster DE. (2018). Benzo Free: The World of Anti-Anxiety Drugs and the Reality of Withdrawal. Denim Mountain Press.
• Frederick, B. (2017). Recovery and renewal: Your essential guide to overcoming dependency and withdrawal from sleeping oills, other benzodiazepine tranquillisers, and anti-depressants. Jessica Kingsley Publishers.
• Greenberg MI. (2001). Benzodiazepine withdrawal: Potentially fatal, commonly missed following benzodiazepine cessation, withdrawal symptoms may begin within 24 hours or take up to two weeks to develop. Emergency Medicine News. https://journals.lww.com/em-news/full-text/2001/12000/benzodiazepine_withdrawal_potentiallyfatal,.13.aspx.
• Groshkova, T., Best, D., & White, W. (2013). The Assessment of Recovery Capital: properties and psychometrics of a measure of addiction recovery strengths. Drug and alcohol review, 32(2), 187–194. https://doi.org/10.1111/j.1465-3362.2012.00489.x
• Gucciardi, E., Jean-Pierre, N., Karam, G., & Sidani, S. (2016). Designing and delivering facilitated storytelling interventions for chronic disease self-management: a scoping review. BMC health services research, 16, 249. https://doi.org/10.1186/s12913-016-1474-7
• Hoffmann F. (2013). Benefits and risks of benzodiazepines and Z-drugs: comparison of perceptions of GPs and community pharmacists in Germany. German medical science : GMS e-journal, 11, Doc10. https://doi.org/10.3205/000178
• Isacsson, G., Holmgren, P., Druid, H., & Bergman, U. (1999). Psychotropics and suicide prevention. Implications from toxicological screening of 5281 suicides in Sweden 1992-1994. The British journal of psychiatry : the journal of mental science, 174, 259–265. https://doi.org/10.1192/bjp.174.3.259
• Lann, M. A., & Molina, D. K. (2009). A fatal case of benzodiazepine withdrawal. The American journal of forensic medicine and pathology, 30(2), 177–179. https://doi.org/10.1097/PAF.0b013e3181875aa0
• Lugoboni, F., & Quaglio, G. (2014). Exploring the dark side of the moon: the treatment of benzodiazepine tolerance. British journal of clinical pharmacology, 77(2), 239–241. https://doi.org/10.1111/bcp.12148
• National Institute on Drug Abuse. (2018) Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition). https://nida.nih.gov/download/675/principles-drug-addiction-treatment-research-based-guide-third-edition.pdf?v=74dad603627bab89b93193918330c223.
• National Institute on Drug Abuse. (2018). Research suggests benzodiazepine use is high while use disorder rates are low. National Institute on Drug Abuse. Published October 18, 2018. Accessed June 26, 2022. https://nida.nih.gov/news-events/science-highlight/research-suggests-benzodiazepine-use-high-while-use-disorder-rates-are-low.
• Olfson, M., King, M., & Schoenbaum, M. (2015). Benzodiazepine use in the United States. JAMA psychiatry, 72(2), 136–142. https://doi.org/10.1001/jamapsychiatry.2014.1763
• Overton, S. L., & Medina, S. L. (2008). The stigma of mental illness. Journal of Counseling & Development, 86(2), 143–151. https://doi.org/10.1002/j.1556-6678.2008.tb00491.x
• Ponte, M. L., Wachs, L., Wachs, A., & Serra, H. A. (2017). Prescribing cascade. A proposed new way to evaluate it. Prescripción en cascada. Una nueva propuesta para evaluarla. Medicina, 77(1), 13–16.
• Prochaska, J. O., & DiClemente, C. C. (1986). Toward a comprehensive model of change. In W. R. Miller & N. Heather (Eds.), Treating addictive behaviors: Processes of change (pp. 3–27). Plenum Press. https://doi.org/10.1007/978-1-4613-2191-0_1
• Reid Finlayson, A. J., Macoubrie, J., Huff, C., Foster, D. E., & Martin, P. R. (2022). Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey. Therapeutic advances in psychopharmacology, 12, 20451253221082386. https://doi.org/10.1177/20451253221082386
• Reisfield, G. M., & Webster, L. R. (2013). Benzodiazepines in long-term opioid therapy. Pain medicine (Malden, Mass.), 14(10), 1441–1446. https://doi.org/10.1111/pme.12236
• Salzman C. (1998). Addiction to benzodiazepines. The Psychiatric quarterly, 69(4), 251–261. https://doi.org/10.1023/a:1022125929946
• Santo, L., Rui, P., & Ashman, J. J. (2020). Physician Office Visits at Which Benzodiazepines Were Prescribed: Findings From 2014-2016 National Ambulatory Medical Care Survey. National health statistics reports, (137), 1–16.
• Warlick H.G., De Souza G.N., & Gallicchio, V.S. (2020). Restoration of gabaa receptor function after benzodiazepine use: A meta-analysis. Journal Of Stem Cell Research. 1(1):1-19. doi:10.52793/jscr.2020.1(1)-05 Witt-Doerring, Josef & Shorter, Daryl & Kosten, T.. (2018). Online communities for drug withdrawal: What can we learn?. Psychiatric Times. 35. 1-4+14.